Reach Us +447482877761
An Integrated Approach To Virtual Screening: From Genomes To Molecules | 9385
ISSN: 0974-7230

Journal of Computer Science & Systems Biology
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

16th World Congress on Structural Biology

Amsterdam, Netherlands
Share This Page

An integrated approach to virtual screening: From genomes to molecules

International Conference on Integrative Biology Summit

Rafael Najmanovich

Accepted Abstracts: J Comput Sci Syst Biol

DOI: 10.4172/0974-7230.S1.004

In this talk we how the five axes of research in the Najmanovich Research Group (NRG) are integrated within a rational drug design approach to the detection of novel modulators of the function of biological macromolecules. Starting from the utilization of systems biology methods for the detection of essential targets, the utilization of ENCoM, a sequence-specific normal-modes- based method for the simulation of large-scale movements in proteins used to study dynamic aspects of protein function, predict the effect of mutations and generate conformational ensembles. The use of FlexAID, a genetic-algorithm-based docking method with ligand and side-chain flexibility. The detection of molecular similarities with IsoCleft and IsoMIF for the identification of potential cross-reactivity targets (or their exploitation in polypharmacology). We demonstrate these tools in the ligand-biased modelling of GPCRs and the virtual screening of peptidic inhibitors against Matriptase and screening against essential C. difficile targets. Such tools allow us to approach virtual screening in an integrated way from genomes to molecules.